YOLFTbeta
00

Teyi Pharmaceutical Group Co Ltd

002728 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

9.12CNY-0.03 (-0.33%)

Price History

Full chart

Market Stats

Previous Close9.15
Open9.10
Day Range8.94 – 9.29
52-Week Range7.66 – 14.93
Volume20.22M
Market Cap5.09B
P/E (TTM)70.79
Forward P/E0.00
EPS0.14
Dividend Yield1.51%
Beta1.34
50-Day Avg9.20
200-Day Avg10.23

About

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People's Republic of China. The company's products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. The company was founded in 2002 and is based in Taishan, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Xiliang Chen
  • Employees1.43K
  • HeadquartersNo. 9, 11, Changxing Road, Taishan, China, 529200, China
  • Websitehttps://www.tczy.com.cn

Leadership

  • Mr. Xiliang ChenCFO, Deputy GM & Director · b. 1972
  • Mr. Yongzhao ZhangDeputy General Manager · b. 1982
  • Mr. Wei Cheng WuDeputy General Manager · b. 1969
  • Mr. Wen Ge YanDeputy General Manager · b. 1966
  • Bi Jian CaiAccounting Supervisor

Financials

Income Statement

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue202.14M250.81M305.13M340.83M342.72M344.75M516.54M655.86M686.94M884.98M921.12M632.70M758.16M886.57M1.07B687.79M915.67M
Growth (%)-+24.08%+21.66%+11.70%+0.56%+0.59%+49.83%+26.97%+4.74%+28.83%+4.08%-31.31%+19.83%+16.94%+20.38%-35.55%+33.13%
Cost of Revenue151.39M163.56M183.68M198.75M193.79M192.40M282.77M343.12M355.55M365.21M374.61M330.93M356.12M451.83M467.98M386.47M449.42M
Gross Profit50.75M87.25M121.45M142.08M148.93M152.35M233.77M312.73M331.39M519.76M546.51M301.76M402.04M434.74M599.23M301.32M466.26M
Gross Margin25.11%34.79%39.80%41.69%43.46%44.19%45.26%47.68%48.24%58.73%59.33%47.69%53.03%49.04%56.15%43.81%50.92%
Operating Expense23.57M33.72M44.44M55.79M55.66M62.05M142.00M212.25M214.36M337.85M348.94M243.54M261.47M238.19M305.96M277.20M388.28M
Operating Income27.18M53.53M77.01M86.29M93.27M90.30M91.77M100.48M117.03M181.92M197.58M58.22M140.57M196.55M293.27M24.12M77.98M
Operating Margin13.44%21.34%25.24%25.32%27.21%26.19%17.77%15.32%17.04%20.56%21.45%9.20%18.54%22.17%27.48%3.51%8.52%
EBITDA34.87M60.57M88.27M98.43M100.74M102.64M114.14M155.05M173.76M260.06M288.69M147.52M228.24M278.45M369.91M92.30M147.31M
EBITDA Margin17.25%24.15%28.93%28.88%29.39%29.77%22.10%23.64%25.29%29.39%31.34%23.32%30.10%31.41%34.66%13.42%16.09%
Net Income24.10M47.98M69.69M78.58M80.55M80.19M81.11M94.78M106.34M155.55M171.71M43.82M126.92M178.20M253.18M20.50M81.67M
Net Income Margin11.92%19.13%22.84%23.06%23.50%23.26%15.70%14.45%15.48%17.58%18.64%6.93%16.74%20.10%23.72%2.98%8.92%
R&D--13.98M15.37M16.28M17.98M28.44M53.34M48.44M46.63M44.38M36.50M37.78M38.01M43.06M49.54M40.82M
R&D as % of Total Revenue--4.58%4.51%4.75%5.22%5.51%8.13%7.05%5.27%4.82%5.77%4.98%4.29%4.04%7.20%4.46%
Interest Expense1.31M657.34K411.58K105.22K85.21K74.51K4.04M17.33M18.21M40.78M46.21M43.21M29.84M29.60M16.81M5.88M4.56M
Interest Expense % of Total Revenue0.65%0.26%0.13%0.03%0.02%0.02%0.78%2.64%2.65%4.61%5.02%6.83%3.94%3.34%1.57%0.86%0.50%

Balance Sheet

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets189.65M252.73M283.21M388.22M453.54M825.60M1.60B1.60B1.93B2.07B2.26B2.26B2.07B2.55B2.51B2.40B2.31B
Total Liabilities86.47M81.92M57.71M102.88M103.40M89.96M793.78M716.61M886.14M956.39M1.10B1.18B804.51M1.14B501.95M635.94M472.69M
Total Equity103.18M170.81M225.51M285.34M350.14M735.64M804.30M886.57M1.04B1.11B1.15B1.08B1.26B1.40B2.01B1.76B1.82B
Cash19.50M57.25M90.77M150.10M162.80M500.29M245.27M153.85M216.88M460.62M123.60M325.12M372.47M739.66M647.25M457.41M126.15M
Total Debt36.54M12.64M----363.62M403.19M673.32M791.23M974.89M1.04B662.18M847.18M306.00M516.09M277.14M
Net Debt17.03M-44.60M-90.77M-150.10M-162.80M-500.29M118.35M249.34M456.44M330.61M851.29M717.12M289.71M107.52M-341.25M58.68M150.98M

Cash Flow

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow22.32M46.92M69.81M104.50M74.23M57.35M68.87M101.30M102.96M187.97M221.64M168.99M256.81M371.66M198.56M-22.55M244.88M
Investing Cash Flow-16.84M-9.73M3.44M-24.24M-43.15M-26.98M-667.66M-242.15M-340.80M63.75M-575.21M125.82M147.25M-103.33M-85.53M-109.80M-289.35M
Financing Cash Flow-6.23M-5.88M-28.56M-13.09M-15.48M307.12M343.42M49.49M300.53M-7.67M16.52M-93.30M-356.73M-101.17M-105.44M-111.51M-132.86M
Capital Expenditure4.02M3.29M7.72M32.20M46.05M26.98M101.24M170.85M40.63M152.44M130.79M89.42M109.58M90.26M86.05M113.56M79.55M
Free Cash Flow18.29M43.62M62.09M72.30M28.18M30.36M-32.37M-69.56M62.32M35.53M90.85M79.57M147.24M281.39M112.51M-136.11M165.34M
Dividends Paid7.75M11.10M15.41M18.75M15.75M16.50M17.38M30.05M31.92M118.45M149.85M163.97M138.38M147.62M149.02M182.31M24.95M
FCF to OCF81.96%92.98%88.94%69.19%37.96%52.95%-47.01%-68.67%60.53%18.90%40.99%47.09%57.33%75.71%56.66%603.59%67.52%
Dividend Paid to FCF42.36%25.45%24.82%25.93%55.89%54.34%-53.68%-43.20%51.22%333.44%164.94%206.07%93.99%52.46%132.45%-133.94%15.09%

Earnings

Report DateSep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 23, 2016Oct 24, 2016Feb 23, 2017Apr 21, 2017Jul 25, 2017Oct 25, 2017Jan 19, 2018Apr 30, 2018Aug 8, 2018Oct 15, 2018Feb 27, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Mar 27, 2020Apr 29, 2020Aug 26, 2020Oct 27, 2020Dec 31, 2020Apr 28, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 7, 2024Apr 19, 2024Jul 25, 2024Oct 25, 2024Dec 31, 2024Apr 25, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------
EPS Actual0.050.040.050.050.060.050.050.120.110.140.090.180.140.120.120.250.220.170.100.120.110.190.110.020.010.040.200.080.070.060.110.040.080.180.220.100.080.180.03-0.010.010.030.060.010.050.030.050.01
Surprise------------------------------------------------
Timing-------Pre-marketPre-marketAfter-hoursPre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-------------------Pre-marketAfter-hoursPre-marketPre-market-Pre-market-----

Key Statistics & Ratios

Market Cap5.09B
Enterprise Value4.92B
Trailing P/E70.79
Forward P/E0.00
Price / Sales6.15
Price / Book2.84
EPS0.14
Book Value3.48
Revenue (TTM)826.71M
Gross Profit (TTM)431.44M
EBITDA146.51M
Profit Margin9.05%
Operating Margin4.18%
Return on Equity4.21%
Return on Assets1.96%
Shares Outstanding513.31M
Shares Float305.15M
Beta1.34
Dividend Yield1.51%
Dividend Rate0.15
Payout Ratio100.20%

Dividends

20261×
0.15Jun 18, 2026
20251×
0.05Jul 25, 2025
20241×
0.36Apr 24, 2024
20231×
0.33May 26, 2023
20221×
0.33May 10, 2022
20211×
0.33Jun 3, 2021
20201×
0.38Apr 28, 2020
20191×
0.33Mar 29, 2019
20181×
0.26Apr 20, 2018
20171×
0.04Aug 11, 2017
20161×
0.03Aug 25, 2016
20151×
0.04Jul 3, 2015

Stock Splits

  • Apr 24, 20241.4:1
  • May 26, 20231.4:1
  • Jul 3, 201520:10